ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Cabozantinib in prostate cancer: the beginning of a precision paradigm?

Susan Goodin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.